Liver Disease Information
In Your Area
American Liver Foundation
39 Broadway, Suite 2700
New York, New York 10006
212-668-1000 Tel
212-483-8179 Fax
Browse Related Terms
Home > About Us > About Advocacy > Incarcerated Persons
Centers for Disease Control and Prevention (CDC)
Consultants Meeting to Develop Recommendations for the Prevention and Control of Viral Hepatitis Among Incarcerated Persons
All individuals with chronic hepatitis, including those who are incarcerated, need access to immunization, testing and, when appropriate, treatment. Given the high prevalence of chronic hepatitis B and C, and the potential risk for acute hepatitis A and B infection, in incarcerated populations, we support the following principles:
Education and Counseling
Educational programs within correctional systems should permit incarcerated persons to:
Testing
Testing for hepatitis B and C should be available within correctional systems on a routine basis or for persons for whom it is indicated.
Treatment
When it is medically advisable, treatment for chronic hepatitis B or C should be made available within the prison system. Ongoing medical care should be made available for all incarcerated persons who decline or are ineligible for treatment.
Vaccination
Hepatitis A and B vaccines should be provided for all persons with chronic hepatitis C.
Hepatitis A vaccine should be made available for all incarcerated persons with chronic hepatitis B or any other form of chronic liver disease.
Due to the fact that incarcerated persons are at risk for viral hepatitis, vaccination for hepatitis A and B should be encouraged within correctional systems.
Page updated: October 4th, 2011
© Copyright 2013 American Liver Foundation. All Rights Reserved. The American Liver Foundation is a member of the World Hepatitis Alliance.